期刊文献+

PRT318对胶原诱导人血小板Syk磷酸化的影响

Effect of PRT318 on collagen-induced Syk phosphorylation in human platelets
下载PDF
导出
摘要 目的观察脾酪氨酸激酶(Syk)抑制剂PRT060318(PRT318)在体外对人血小板聚集率及Syk磷酸化的影响。方法采用比浊法测定PRT318对胶原、二磷酸腺苷(ADP)及花生四烯酸(AA)诱导的人血小板聚集率的影响;运用Western blot检测Syk525/6磷酸化水平。结果 Syk特异性抑制剂PRT318可抑制胶原诱导的人血小板聚集率,但对ADP或AA诱导的人血小板聚集率无影响。在蛋白水平上PRT318可促进人血小板在胶原诱导下Syk525/6磷酸化水平升高。酪氨酸蛋白激酶抑制剂PP2可抑制胶原诱导的人血小板聚集,降低人血小板在胶原诱导下Syk525/6磷酸化水平,并可阻断胶原诱导下PRT318促Syk525/6磷酸化作用。结论 PRT318对胶原诱导的血小板聚集具有抑制作用,并能促进胶原诱导的血小板膜受体糖蛋白VI信号通路上Syk525/6磷酸化,提示PRT318可能通过作用于Syk525/6磷酸化而抑制血小板聚集。 Objective To observe the effect of PRT060318 (PRT318), an inhibitor of spleen tyrosine ki- nase (Syk), on human platelet aggregation and Syk phosphorylation in vitro. Methods The effect of PRT318 on platelet aggregation induced by collagen, adenosine diphosphate (ADP) and araehidonic acid (AA) was measured by turbidimetry. The phosphorylation of Syk525/6 was detected by Western blot. Results The Syk- specific inhibitor PRT318 suppressed collagen-induced platelet aggregation, while it did not have significantly inhibitory effect on ADP- or AA-induced platelet aggregation. The present data showed that PRT318 promoted the phosphory|ation of Syk525/6 in collagen-induced platelets. PP2, tyrosine protein kinase (Src) inhibitor, inhibited collagen-induced platelet aggregation and decreased the level of Syk525/6 phosphorylation induced by collagen. PP2 also blocked PRT318-enhaneed Syk525/6 phosphorylation in collagen-treated platelets. Conclusions PRT318 significantly inhibits collagen-induced platelet aggregation and promotes collagen-induced phosphorylation of Syk525/6 locating in the downstream of glyeoprotein VI (GPVI) signal pathway, suggesting that PRT318 may inhibit platelet activation through regulating Syk525/6 phosphorylation.
出处 《中国现代医学杂志》 CAS 北大核心 2017年第9期39-43,共5页 China Journal of Modern Medicine
基金 国家自然科学基金(No:81072968) 教育部留学回国人员科研启动基金[No:教外司(20011568)] 河南省重点科技攻关项目(No:102102310334)
关键词 PRT318 胶原 血小板集聚 Syk525/6磷酸化 PRT318 collagen platelet aggregation phosphorylation of Syk525/6
  • 相关文献

参考文献1

二级参考文献21

  • 1Andrews RK, Arthur JF, Gardiner EE. Targeting GPVI as a novel antithrombotic strategy[J]. J Blood Med, 2014, 5:59 -68.
  • 2Gardiner EE, Andrews RK. Platelet receptor expression and shed- ding: glycoprotein Ib-IX-V and glycoprotein VI [J]. Transfus Med Rev, 2014, 28(2) : 56 -60.
  • 3Berndt MC, Metharom P, Andrews RK, et al. Primary haemostasis: newer insights [ J]. Haemophilia, 2014, 20 ( Suppl 4 ) : 15 - 22.
  • 4Zahid M, Mangin P, Loyau S, et al. The future of glycoprotein VI as an antithrombotic target [J]. J Thromb Haemost, 2012, 10 (12) : 2418 -2427.
  • 5Alshahrani MM, Yang E, Yip J, et al. CEACAM2 negatively regu- lates hemi (ITAM-bearing) GP V/ and CLEC-2 pathways and thrombus growth in vitro and in vivo[ J]. Blood, 2014, 124 (15) : 2431 - 2441.
  • 6Kim S, Dangelmaier C, Bhavanasi D, et al. RhoG protein regulates glycoprotein V[-Fc receptor gamma-chain complex-mediated platelet activation and thrombus formation [ J]. J Biol Chem, 2013, 288 (47) : 34230 - 34238.
  • 7Walsh TG, Berndt MC, Carrim N, et al. The role of Noxl and Nox2 in GPVI-dependent platelet activation and thrombus formation[J]. Redox Biol, 2014, 2: 178- 186.
  • 8Taylor L, Vasudevan SR, Jones CI, et al. Discovery of novel GPVIreceptor antagonists by structure-based repurposing[J]. PloS One, 2014,9(6) : e101209.
  • 9Arthur JF, Dunkley S, Andrews RK, et al. Platelet glycoprotein VI- related clinical defects[J]. Br J Haematol, 2007, 139(3) : 363 - 372.
  • 10Kato K, Kanaji T, Russell S, et al. The contribution of glycoproteinVI to stable platelet adhesion and thromhus formation illustrated by targeted gene deletion[ J]. Blood, 2003, 102(5) : 1701 - 1707.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部